Simpler Grants.gov #RFA-HL-27-004

NHLBI Small Grant Program for K Award Recipients (R03 Clinical Trial Optional)

The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is offering a small grant program (R03 Clinical Trial Optional) for select early-career researchers: - Government Buyer: - National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI) - Targeted at current or recently completed NHLBI K01, K08, K23, and K25 awardees - Purpose: - Support expansion of research objectives or initiation of new studies derived from K award research - Projects must be feasible within two years and with limited resources - Eligible project types include pilot studies, proof of concept, secondary data analysis, new methodology development, or creation of novel experimental model systems - Requirements: - Applicants must maintain at least 40% protected research effort during the award period - Only U.S.-based organizations are eligible; foreign entities and components are excluded - Funding Details: - Total available funding: $3,900,000 - Expected number of awards: 29 - No specific OEMs, vendors, or product/service procurements are involved, as this is a research grant opportunity

Description

This Notice of Funding Opportunity (NOFO) invites applications from eligible organizations for a limited competition small grant program targeting current or recently completed NHLBI K01, K08, K23, and K25 awardees. The purpose is to provide small grant support to expand current research objectives or branch out to new studies emerging from their K award research, facilitating the transition to research independence. The R03 grant supports projects that can be completed within two years with limited resources, including pilot studies, proof of concept, secondary data analysis, and development of new methodologies. Applicants must maintain a minimum of 40% protected research effort during the award period.

View original listing